Tapewire

Nasdaq · USD

PTCT

PTC THERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
3803
SEC CIK
0001070081
Parsed reports
477

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025039
Dec 2025021
Jan 2026042
Feb 2026014
Mar 202606
Apr 202607
May 2026010
Jun 2026018
Jul 2026020
Aug 2026012
Sep 202608
Oct 202605

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantStock Option (Right to Buy) · Derivative 6,950 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001288952-26-000002 · form4-01062026_050106.xml · derivative · entry 2

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,950

Underlying: Common Stock · 6,950 shares

Expires 2036-01-01

F2 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantCommon Stock 8,000 $0.00 $0.00
Disclosure

SEC source: 0001288952-26-000002 · form4-01062026_050106.xml · nonDerivative · entry 1

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,266

F1 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001984065-26-000002 · form4-01062026_050105.xml · derivative · entry 2

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-01-01

F3 · derivative.exercise_date: This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Gravier PierreCHIEF FINANCIAL OFFICER
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001984065-26-000002 · form4-01062026_050105.xml · nonDerivative · entry 1

Gravier Pierre · CIK 0001984065 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,449

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

F2 · balance_after: Includes 272 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended June 30, 2025, and 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
GrantStock Option (Right to Buy) · Derivative 157,500 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001808968-26-000003 · form4-01062026_050103.xml · derivative · entry 2

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,500

Underlying: Common Stock · 157,500 shares

Expires 2036-01-01

F3 · derivative.exercise_date: This option was granted on January 2, 2026, and vests over four years, with 25% of the shares underlying the option vesting on January 2, 2027, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 63,000 $0.00 $0.00
Disclosure

SEC source: 0001808968-26-000003 · form4-01062026_050103.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 405,132

F1 · shares: Restricted stock units granted on January 2, 2026 that vest in four equal installments over four years, commencing on January 2, 2027.

F2 · balance_after: Includes 257 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ended December 31, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantStock Option (Right to Buy) · Derivative 3,475 $0.00 Strike: $76.74 $0.00
Disclosure

SEC source: 0001269131-26-000003 · form4-01062026_050101.xml · derivative · entry 5

STEELE GLENN JR MD PHD · CIK 0001269131 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,475

Underlying: Common Stock · 3,475 shares

Expires 2036-01-01

F4 · derivative.exercise_date: This option was granted on January 2, 2026 and vests over one year in twelve equal monthly installments, commencing on February 2, 2026.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 12,000 $0.00 Strike: $30.86 $0.00
Disclosure

SEC source: 0001269131-26-000003 · form4-01062026_050101.xml · derivative · entry 4

STEELE GLENN JR MD PHD · CIK 0001269131 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,000 shares

Expires 2026-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.

F3 · derivative.exercise_date: Currently exercisable.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC GrantCommon Stock 4,000 $0.00 $0.00
Disclosure

SEC source: 0001269131-26-000003 · form4-01062026_050101.xml · nonDerivative · entry 3

STEELE GLENN JR MD PHD · CIK 0001269131 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,500

F2 · shares: Restricted stock units granted on January 2, 2026 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 2, 2026 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 2, 2027.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC SaleCommon Stock 12,000 $76.35 $916,200.00
Disclosure

SEC source: 0001269131-26-000003 · form4-01062026_050101.xml · nonDerivative · entry 2

STEELE GLENN JR MD PHD · CIK 0001269131 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,500

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.

Read SEC document
January 02, 2026 Filed Jan 6, 2026 22:20 UTC Exercise / conversionCommon Stock 12,000 $30.86 $370,320.00
Disclosure

SEC source: 0001269131-26-000003 · form4-01062026_050101.xml · nonDerivative · entry 1

STEELE GLENN JR MD PHD · CIK 0001269131 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 8, 2025.

Read SEC document
December 30, 2025 Filed Jan 2, 2026 22:20 UTC
Klein Matthew B.Director · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 8,089 $76.64 $619,940.96
Disclosure

SEC source: 0001808968-26-000001 · form4-01022026_050101.xml · nonDerivative · entry 1

Klein Matthew B. · CIK 0001808968 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 341,875

F1 · shares: Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 19,805 $0.00 Strike: $66.49 $0.00
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · derivative · entry 16

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,805 shares

Expires 2031-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F12 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 565 $0.00 Strike: $18.01 $0.00
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · derivative · entry 15

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,566

Underlying: Common Stock · 565 shares

Expires 2028-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F12 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 138 $0.00 Strike: $66.49 $0.00
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · derivative · entry 14

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,805

Underlying: Common Stock · 138 shares

Expires 2031-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F12 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 3,220 $78.33 $252,222.60
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 13

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F11 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.13 to $78.56 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 10,548 $77.55 $817,997.40
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 12

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,593

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F10 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.10 to $78.02 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 4,537 $76.33 $346,309.21
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 11

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 84,141

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F9 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.05 to $76.77 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 1,500 $75.77 $113,655.00
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 10

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,678

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F8 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.05 to $76.01 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 19,805 $66.49 $1,316,834.45
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 9

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 59 $78.43 $4,627.37
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 8

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F7 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.34 to $78.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 313 $77.73 $24,329.49
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 7

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,432

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.25 to $78.22 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 193 $75.45 $14,561.85
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 6

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,745

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.04 to $75.91 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 565 $18.01 $10,175.65
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 5

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 59 $78.01 $4,602.59
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 4

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $77.65 to $78.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 42 $77.26 $3,244.92
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 3

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,432

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $76.60 to $77.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 37 $75.66 $2,799.42
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 2

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,474

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.20 to $76.08 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 19, 2025 Filed Dec 23, 2025 22:15 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 138 $66.49 $9,175.62
Disclosure

SEC source: 0001323212-25-000006 · form4-12232025_051201.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 251 $0.00 Strike: $18.01 $0.00
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · derivative · entry 18

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,131

Underlying: Common Stock · 251 shares

Expires 2028-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F7 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 2,951 $0.00 Strike: $66.49 $0.00
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · derivative · entry 17

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,943

Underlying: Common Stock · 2,951 shares

Expires 2031-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F7 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 2,831 $75.07 $212,523.17
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 14

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F6 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.20 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 2,831 $66.49 $188,233.19
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 13

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,204

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 251 $75.00 $18,825.00
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 12

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 251 $18.01 $4,520.51
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 11

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 120 $75.02 $9,002.40
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 10

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F5 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.18 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 18, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 120 $66.49 $7,978.80
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 9

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,493

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 3,684 $0.00 Strike: $18.01 $0.00
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · derivative · entry 16

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,382

Underlying: Common Stock · 3,684 shares

Expires 2028-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F7 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionStock Option (Right to Buy) · Derivative 36,606 $0.00 Strike: $66.49 $0.00
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · derivative · entry 15

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,894

Underlying: Common Stock · 36,606 shares

Expires 2031-01-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F7 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 100 $76.00 $7,600.00
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 8

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 35,261 $75.44 $2,660,089.84
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 7

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,473

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F4 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 35,361 $66.49 $2,351,152.89
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 6

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,734

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 100 $76.00 $7,600.00
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 5

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,373

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 3,584 $75.31 $269,911.04
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 4

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,473

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F3 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 3,684 $18.01 $66,348.84
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 3

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
SaleCommon Stock 1,245 $75.28 $93,723.60
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 2

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,912

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

F2 · price: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $75.00 to $75.55 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
December 17, 2025 Filed Dec 19, 2025 22:20 UTC
Pauwels EricCHIEF BUSINESS OFFICER
Exercise / conversionCommon Stock 1,245 $66.49 $82,780.05
Disclosure

SEC source: 0001323212-25-000003 · form4-12192025_051201.xml · nonDerivative · entry 1

Pauwels Eric · CIK 0001323212 · CHIEF BUSINESS OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 15, 2025.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 22:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $30.86 $0.00
Disclosure

SEC source: 0001288952-25-000004 · form4-12182025_051201.xml · derivative · entry 2

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 24,000 shares

Expires 2026-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Currently exercisable.

Read SEC document
December 16, 2025 Filed Dec 18, 2025 22:20 UTC Exercise / conversionCommon Stock 24,000 $30.86 $740,640.00
Disclosure

SEC source: 0001288952-25-000004 · form4-12182025_051201.xml · nonDerivative · entry 1

SCHMERTZLER MICHAEL · CIK 0001288952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,266

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 22:20 UTC
Reeve EmmaDirector
Exercise / conversionStock Option (Right to Buy) · Derivative 733 $0.00 Strike: $46.54 $0.00
Disclosure

SEC source: 0001680329-25-000014 · form4-12052025_051201.xml · derivative · entry 3

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 734

Underlying: Common Stock · 733 shares

Expires 2035-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.

F2 · derivative.exercise_date: This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.

Read SEC document
December 03, 2025 Filed Dec 5, 2025 22:20 UTC
Reeve EmmaDirector
SaleCommon Stock 733 $78.62 $57,628.46
Disclosure

SEC source: 0001680329-25-000014 · form4-12052025_051201.xml · nonDerivative · entry 2

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,666

F1 · kind: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.